Drug Database
VA

varicella zoster immunoglobulin (VariQuin)

✓ Approved

Prothya Biosolutions · Polyclonal Antibodies · Polyclonal Antibodies

What is varicella zoster immunoglobulin?

varicella zoster immunoglobulin is a polyclonal antibodies developed by Prothya Biosolutions. It is approved for therapeutic indications via injectable (others) or intramuscular (im) injection.

Drug Profile

Brand NamesVariQuin
CompanyProthya Biosolutions
Drug ClassPolyclonal Antibodies, Cell-based Therapies, Antibody
RouteInjectable (Others), Intramuscular (IM) Injection
StatusApproved

Therapeutic Indications

varicella zoster immunoglobulin is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Infections and infestationsVaricella zoster virus infection✓ Approved

Related Research Articles

PubMedJournal of virology2026-11-11

A human sensory neuron model for varicella-zoster virus latency and reactivation in vitro.

Havelaar Alexander C AC, Flot Joseph S JS, Fukuda Saori S, de Jong Anja W M AWM et al.

Varicella-zoster virus (VZV) is a ubiquitous human neurotropic alphaherpesvirus that establishes lifelong latency in sensory ganglionic neurons. Subsequent viral reactivation causes herpes zoster, a morbid disease often complicated by neuropathic pain. Mechanisms underlying VZV latency and reactivation are not understood, mostly due to the lack of permissive animal models and challenges of current in vitro latency modeling. Here, we evaluated HD10.6 cells, a simplified and easily expandable human sensory neuron line to model VZV latency and reactivation. Differentiated HD10.6 (dHD10.6) neurons supported productive VZV infection, viral DNA replication, production of infectious progeny, and viral spread in cultures. VZV infection was associated with limited cytopathic effects and ultrastructural changes. Infecting dHD10.6 neurons with cell-free VZV in the presence of antivirals resulted in a quiescent-persistent state, characterized by persistent VZV genomes with restricted VZV gene expression and absence of infectious virus. Importantly, VZV could be reactivated by treatment with capsaicin, as evidenced by increased lytic viral transcription and virus spread. In conclusion, this study establishes human HD10.6 neurons as a novel and expandable in vitro model for studying VZV latency and reactivation to identify virus and host factors governing latency that may serve as therapeutic targets to restrict VZV reactivation.IMPORTANCEMost individuals carry latent varicella-zoster virus (VZV) in their dorsal root ganglia (DRG), which can reactivate to cause shingles and chronic pain. The mechanisms by which VZV establishes latency and triggers of reactivation are incompletely understood. Current platforms for the study of VZV latency do not easily support functional experiments (ganglia) or are difficult to expand and complicated by mixed neuronal populations (stem cell-derived neurons). Here, we demonstrate that differentiated HD10.6 cells derived from immortalized human DRG-derived neurons provide a clonal and easy-to-expand platform for studying lytic, latent, and reactivated VZV infection in sensory neurons. We propose that the HD10.6 platform could provide the basis to conduct studies on the viral latent state that have hitherto not been possible.

PubMedFrontiers in medicine2026-11-11

Herpes zoster-induced critical rhabdomyolysis with secondary hypothyroidism: a case report.

Lv Xiangkang X, Zhang Bin B, Yang Wei W, Lu Xiao X

Primary varicella-zoster virus (VZV) reactivation causes herpes zoster (HZ), typically presenting with dermatomal rash and neuropathic pain. Rhabdomyolysis as a systemic complication of HZ is extremely rare, and its underlying pathogenesis and optimal management remain poorly characterized, especially in elderly patients. Here we report a 63-year-old female who presented with fever, generalized myalgia, and oliguria, with serum creatine kinase (CK) rapidly escalating from 4,383 U/L to a peak of 186,383 U/L. Further investigation revealed a preceding history of lumbar herpes zoster two weeks prior, accompanied by virus-induced secondary hypothyroidism. Muscle biopsy confirmed extensive myofiber necrosis without inflammatory infiltration, consistent with non-inflammatory rhabdomyolysis. The patient developed acute kidney injury, hepatic dysfunction, and respiratory failure, and was managed with multidisciplinary intensive care including mechanical ventilation, 9 days of continuous renal replacement therapy, glucocorticoid anti-inflammatory therapy, and levothyroxine replacement. After 12 days of treatment, CK decreased to 3,381 U/L with significant recovery of multiorgan function, and the patient was transferred out of the intensive care unit. This case highlights that HZ can trigger life-threatening rhabdomyolysis, possibly via VZV-mediated immune dysregulation and secondary hypothyroidism. Detailed history taking, early CK screening, and multidisciplinary organ support are critical to improve outcomes in this rare but severe condition.

PubMedCureus2026-11-11

Intestinal Paracoccidioidomycosis Masquerading as Crohn's Disease: Diagnostic Pitfalls in a Case Report.

Cerqueira Ana A, Seco Tiago T, Moniz Joana J, Lemos Bárbara B et al.

Paracoccidioidomycosis (PCM) is a systemic fungal infection caused by Paracoccidioides spp., predominantly found in Brazil. It primarily affects the respiratory system, while extrapulmonary involvement is rare. Disseminated PCM in immunocompetent hosts may be associated with exposure burden, host factors, delayed diagnosis, and disease phenotype. We present the case of a 28-year-old Brazilian man who had been living in Portugal for five months and presented to the emergency department with persistent abdominal pain lasting three weeks. Initial evaluation revealed mesenteric lymph-node conglomerates. During hospitalization, an extensive workup was performed, including screening for active neoplastic disease, immunosuppressive states, and active infection. A fourth-generation HIV combined antigen/antibody test was negative. Immunoglobulin levels were within the normal range (immunoglobulin A 160 mg/dL, immunoglobulin M 200 mg/dL and immunoglobulin G 1500 mg/dL). There was no history of immunosuppressive medication use including steroid or biologic, and no history of diabetes or transplantation. There was also no clinical or imaging evidence of solid or haematological malignancy. Immunophenotyping of peripheral blood and two lymph nodes showed no changes of pathological significance. Clinical, imaging, endoscopic, and histologic findings suggested Crohn's disease, although the presentation was atypical because of the extent of painful lymphadenopathy and hepatosplenomegaly. However, Periodic Acid-Schiff (PAS) and Ziehl-Neelsen staining were performed on the initial slides containing granulomas (inguinal lymph node and samples from the ileum and colon, but did not demonstrate evidence of infection at that time). A trial with high-dose corticosteroids was initiated.  Following subsequent deterioration, an axillary lymph-node was excised. Gomori-Grocott (GG) staining, which was only performed at this stage, revealed the "ship's pilot wheel" appearance. There was no isolation in cultures and serologic and polymerase chain reaction (PCR) testing for Paracoccidioides spp. could not be performed at our hospital. Therefore, the diagnosis of paracoccidioidomycosis was established based on histologic morphology, epidemiologic context, and suggestive clinical features. After the diagnosis was established, the initial slides were reviewed and GG staining was added, becoming clear that the fungal forms were already present in all the tested samples, but had gone unrecognized. Imported fungal infections in non-endemic areas present significant clinical challenges, including delayed diagnosis and limited clinician experience. In Portugal, only one private laboratory can perform PCR and serologic testing for paracoccidioidomycosis. This limitation highlights an important lesson from this case: a diagnosis cannot be made if the disease is not considered. This case may therefore serve as a useful resource for settings with similar diagnostic limitations. Given the extreme rarity of extrapulmonary PCM, this case highlights the need for a comprehensive diagnostic approach to intestinal granulomatous diseases, particularly in patients from endemic regions, and emphasizes the role of internal medicine in this diagnostic process.

PubMedFrontiers in public health2026-11-11

Artificial intelligence chatbots as information sources for herpes zoster: an evaluation of patient-education suitability, overall quality, and readability.

Zhang Fengyu F, Tong Pengfei P, Yang Hucai H

Clarify the effects of large-language-model types and health-education content categories on generated-text quality (patient-education suitability, overall quality) and readability, so as to provide empirical evidence for standardized AI-assisted health-communication applications. This cross-sectional study was conducted between July 10 and July 15, 2026. Twenty herpes zoster-related questions were developed by a dermatologist and a pharmacist and categorized into five themes. The questions were then entered into five mainstream large language models (GPT-5, Doubao, DeepSeek, Qianwen, and Gemini), generating 100 textual responses. Response quality was assessed using the Chinese version of the Patient Education Materials Assessment Tool for Printable Materials (C-PEMAT-P) and Global Quality Score (GQS). Readability was evaluated via seven indices including the Automated Readability Index (ARI) and Flesch Reading Ease Score (FRES). Readability outcomes were compared using one-way repeated-measures analysis of variance with Greenhouse-Geisser correction. C-PEMAT-P raw totals and ordinal GQS scores were compared using Friedman tests. Post-hoc comparisons were adjusted using the Holm method. Category-level comparisons were performed using linear mixed-effects models with likelihood-ratio χ2 tests for continuous outcomes and an ordinal generalized estimating equation with a Wald χ2 test for GQS. Significant overall differences among models were observed for all seven readability indices and both assessment scores (all p < 0.001). Median C-PEMAT-P raw total scores were 12.50, 11.00, 10.00, 9.00 and 9.00 for GPT-5, Doubao, DeepSeek, Qianwen and Gemini, respectively; corresponding median GQS scores were 5.00, 4.00, 4.00, 3.00, and 3.00. After Holm correction, GPT-5 achieved higher scores than each of the other models on both assessment measures. However, no significant difference in C-PEMAT-P raw totals was found between DeepSeek and either Qianwen or Gemini, or between Doubao and DeepSeek, after adjustment (all adjusted p = 0.062), and Qianwen and Gemini did not differ significantly (adjusted p = 0.766). The overall effect sizes were Kendall's W = 0.611 for C-PEMAT-P and W = 0.779 for GQS. Exploratory pooled Spearman correlation analysis revealed a positive association between the two assessment scores (ρ = 0.853). Model type is a key determinant of text quality. Readability was independently influenced by both model type and content category, and the two are relatively independent. In clinical applications, GPT-5, DeepSeek, and Doubao are preferred. Readability can be optimized by integrating topic characteristics and patients' health literacy to enhance communication accuracy. Limitations exist in this study regarding sample coverage and evaluation dimensions (the absence of subjective experience data); larger-scale verification should be conducted in future research.

PubMedJPGN reports2026-11-11

A real-world comparison of celiac tissue transglutaminase immunoglobulin A antibody levels in pediatric patients using two different diagnostic kits.

Kori Michal M, Guz-Mark Anat A, Perets Tsachi Tsadok TT, Davidpur Amit A et al.

Pediatric celiac disease (CeD) may be diagnosed without a biopsy when tissue-transglutaminase (TTG) immunoglobulin A (IgA) antibodies are ≥10x the upper limit of normal (ULN) and anti-endomysial antibodies are positive in a second sample. The no-biopsy diagnosis demands a very high accuracy and reliability of the TTG diagnostic kits. Inter-assay differences may affect category classification. We compared TTG-IgA levels performed by two reliable kits: Bioplex 2200 and Liaison-XL in routine care. Using the Clalit Health Services database, we identified pediatric patients with paired TTG-IgA measurements from both kits within ≤14 days. Values were expressed as multiples of ULN and categorized: 10x ULN. Agreement was assessed for ≤7 and ≤14-day windows using Cohen's ĸ. Category discordance occurred in 17.4% (109/625) of paired tests within 14 days and 11.8% (38/321) within 7 days. Overall agreement was substantial (ĸ = 0.62 for 14 days; ĸ = 0.63 for 7 days). Concordance was high for negative results (96.0%), but significantly lower for the critical >10x ULN threshold at 14 days (88.2%, p = 0.009). Significant discordance between these two reliable TTG-IgA kits at 14 days, exceeding 10% in the >10x ULN category, warrants careful consideration when using the no-biopsy approach for CeD diagnosis, as assay choice may impact clinical classification.

PubMedFrontiers in pediatrics2026-11-11

Characteristics of hospitalized children with immunoglobulin A vasculitis: a 7-year retrospective study of 119,217 pediatric inpatients in China.

Ma Yue Y, Wang Xinyu X, Zhang Ningning N, Liu Chang C et al.

Immunoglobulin A vasculitis (IgAV), formerly Henoch-Schonlein purpura (HSP), is the most common systemic vasculitis in children. This study aimed to systematically analyze the demographic, epidemiological, clinical, and infectious characteristics of pediatric IgAV using a large-scale real-world dataset. A retrospective study was conducted using inpatient discharge abstracts from Beijing Children's Hospital, Capital Medical University, spanning January 2016 to December 2022. A total of 119,217 pediatric patients (aged 18 years or younger) diagnosed with IgAV were enrolled. Demographic characteristics, clinical classification, infectious triggers, pathogen spectrum, and multisystem comorbidities and complications were systematically analyzed. Statistical analyses were performed using SPSS 26.0. A two-sided P < 0.05 was considered statistically significant. Among 119,217 enrolled patients, the mean age was 7.79 ± 3.17 years with a male-to-female ratio of 1.30:1. School-aged children (50.77%) and Han ethnicity (93.27%) predominated. Southern China (57.91%) and rural areas (56.91%) showed higher case volumes (both P < 0.001). The winter-spring period (November-March) concentrated 50.66% of cases (P < 0.001). Clinically, unspecified type was most common (57.02%), followed by renal type (20.04%). Renal-type cases showed a significant increasing trend (P < 0.001). Co-infections were present in 47.49% of patients. Mycoplasma pneumoniae was the most frequently recorded pathogen (5.82%), compared with Streptococcus pneumoniae (0.32%). Digestive system complications were most prevalent (4.97%). Pediatric IgAV in this large Chinese inpatient cohort demonstrated male predominance, a winter-spring peak, and an increasing proportion of renal-type classification (from 15.5% to 27.0% over 7 years). Mycoplasma pneumoniae was the most frequently recorded pathogen (5.82%). These findings suggest that systematic multi-pathogen screening (including Mycoplasma pneumoniae) and standardized long-term urinalysis follow-up may be warranted in the management of hospitalized pediatric IgAV patients.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about varicella zoster immunoglobulin